126 related articles for article (PubMed ID: 8510106)
21. Nucleoside conjugates as potential antitumor agents. 2. Synthesis and biological activity of 1-(beta-D-arabinofuranosyl)cytosine conjugates of prednisolone and prednisone.
Hong CI; Nechaev A; West CR
J Med Chem; 1979 Nov; 22(11):1428-32. PubMed ID: 118258
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine.
Lin TS; Yang JH; Liu MC; Shen ZY; Cheng YC; Prusoff WH; Birnbaum GI; Giziewicz J; Ghazzouli I; Brankovan V
J Med Chem; 1991 Feb; 34(2):693-701. PubMed ID: 1995894
[TBL] [Abstract][Full Text] [Related]
23. Antitumor characteristics of the conjugate of N4-(4-carboxybutyryl)-ara-C with ethylenediamine-introduced dextran and its resistance to cytidine deaminase.
Onishi H; Pithayanukul P; Nagai T
Drug Des Deliv; 1990 Oct; 6(4):273-80. PubMed ID: 1707277
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-beta-arabinofuranosylcytosine.
Liu B; Cui C; Duan W; Zhao M; Peng S; Wang L; Liu H; Cui G
Eur J Med Chem; 2009 Sep; 44(9):3596-600. PubMed ID: 19321234
[TBL] [Abstract][Full Text] [Related]
25. Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability.
Matsushita T; Ryu EK; Hong CI; MacCoss M
Cancer Res; 1981 Jul; 41(7):2707-13. PubMed ID: 7248939
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity and pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate: an orally active derivative of 1-beta-D-arabinofuranosylcytosine.
Kodama K; Morozumi M; Saitoh K; Kuninaka A; Yoshino H; Saneyoshi M
Jpn J Cancer Res; 1989 Jul; 80(7):679-85. PubMed ID: 2507491
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine.
Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi J; Ishida T
Cancer Res; 1976 Aug; 36(8):2726-32. PubMed ID: 1277182
[TBL] [Abstract][Full Text] [Related]
28. Alkylthioglycerol prodrugs of foscarnet: synthesis, oral bioavailability and structure-activity studies in human cytomegalovirus-, herpes simplex virus type 1- and human immunodeficiency virus type 1-infected cells.
Beadle JR; Kini GD; Aldern KA; Gardner MF; Wright KN; Richman DD; Hostetler KY
Antivir Chem Chemother; 1998 Jan; 9(1):33-40. PubMed ID: 9875375
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
[TBL] [Abstract][Full Text] [Related]
30. Nucleosides and nucleotides. 122. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine and its derivatives. A new class of nucleoside with a broad antitumor spectrum.
Azuma A; Nakajima Y; Nishizono N; Minakawa N; Suzuki M; Hanaoka K; Kobayashi T; Tanaka M; Sasaki T; Matsuda A
J Med Chem; 1993 Dec; 36(26):4183-9. PubMed ID: 8277499
[TBL] [Abstract][Full Text] [Related]
31. Treatment of leukemia L1210 and P388 by arabinosylcytosine-polysaccharide conjugates.
Novotný L; Balázová E; Sandula J; Ujházy V; Kéry V
Int J Cancer; 1991 Jan; 47(2):281-4. PubMed ID: 1988371
[TBL] [Abstract][Full Text] [Related]
32. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
33. Antineoplastic activity of conjugates of lipids and 1-beta-D-arabinofuranosylcytosine.
Berdel WE; Danhauser S; Schick HD; Hong CI; West CR; Fromm M; Fink U; Reichert A; Rastetter J
Lipids; 1987 Nov; 22(11):943-6. PubMed ID: 3444389
[TBL] [Abstract][Full Text] [Related]
34. Treatment of L1210 murine leukemia with liposome-incorporated N4-hexadecyl-1-beta-D-arabinofuranosyl cytosine.
Schwendener RA; Schott H
Int J Cancer; 1992 May; 51(3):466-9. PubMed ID: 1592536
[TBL] [Abstract][Full Text] [Related]
35. Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues.
Driscoll JS; Marquez VE; Plowman J; Liu PS; Kelley JA; Barchi JJ
J Med Chem; 1991 Nov; 34(11):3280-4. PubMed ID: 1956046
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anticancer and antiviral activities of various 2'- and 3'-methylidene-substituted nucleoside analogues and crystal structure of 2'-deoxy-2'-methylidenecytidine hydrochloride.
Lin TS; Luo MZ; Liu MC; Clarke-Katzenburg RH; Cheng YC; Prusoff WH; Mancini WR; Birnbaum GI; Gabe EJ; Giziewicz J
J Med Chem; 1991 Aug; 34(8):2607-15. PubMed ID: 1652024
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.
Turcotte JG; Srivastava SP; Steim JM; Calabresi P; Tibbetts LM; Chu MY
Biochim Biophys Acta; 1980 Sep; 619(3):619-31. PubMed ID: 7459369
[TBL] [Abstract][Full Text] [Related]
38. Preparation, properties and antileukemic activity of arabinosylcytosine polysaccharide conjugates.
Kéry V; Novotný L; Tihlárik K; Haplová J; Kacuráková M; Sandula J; Balázová E
Int J Biochem; 1990; 22(10):1203-7. PubMed ID: 2289626
[TBL] [Abstract][Full Text] [Related]
39. N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent.
Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi JI; Ishida T
Cancer Res; 1977 Aug; 37(8 Pt 1):2481-6. PubMed ID: 872077
[TBL] [Abstract][Full Text] [Related]
40. Reactions of 2-acyloxyisobutyryl halides with nucleosides. Synthesis and biological evaluation of some 3"-acyl and 3',5'-diacyl derivatives of 1-beta-D-arabinofuranosylcytosine.
Hamamura EK; Prystasz M; Verheyden JP; Moffatt JG
J Med Chem; 1976 May; 19(5):667-74. PubMed ID: 178873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
